Header Logo

Connection

STEVEN I SHERMAN to Thyroid Carcinoma, Anaplastic

Back to Details
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Thyroid Carcinoma, Anaplastic.
STEVEN I SHERMAN
Connection Strength
0.279
Thyroid Carcinoma, Anaplastic
  1. Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer. J Clin Oncol. 2021 07 20; 39(21):2359-2366.
    View in: PubMed
    Score: 0.150
  2. Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling. Head Neck. 2019 06; 41(6):1928-1934.
    View in: PubMed
    Score: 0.129
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.